Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dimethyl Fumarate in Preserving Islet β-Cell Function in Newly Diagnosed Type 1 Diabetes
NCT07258394Phase 3Recruiting
- Sponsor
- Nanjing Medical University
- Start
- Jan 2026
- Primary completion
- Dec 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dimethyl fumarate in type 1 diabetes mellitus (T1D), sponsored by Nanjing Medical University. Started Jan 2026; status: recruiting.
02
Drugs
dimethyl fumarate
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT07258394.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07258394.